When you read about what some startups are doing these days it seems like you're reading a sci-fi book. Earlier this year we published an article titled "3 Companies Building Nanorobot Companies" and we talked about using software, robots, and synthetic biology to engineer synthetic organisms (essentially nanorobots) that can be used to create efficiencies. According to BCC Research, the global market for microbes and microbial products was projected to approach 154.7 billion in 2015 and almost double to 306 billion by 2020. Healthcare is largest consumer of microbes (61%) followed by energy (24%) and manufacturing (13%). The massive size of the microbe industry is just begging for a bit of disruptive technology to address it and that's exactly what Zymergen is getting up to.

Scientists in the US have succeeded in developing the first living cell to be controlled entirely by synthetic DNA. The researchers constructed a bacterium's "genetic software" and transplanted it into a host cell. The resulting microbe then looked and behaved like the species "dictated" by the synthetic DNA. The advance, published in Science, has been hailed as a scientific landmark, but critics say there are dangers posed by synthetic organisms. Some also suggest that the potential benefits of the technology have been over-stated.